Clinical Trial Update: Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subject [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for Ammoxetine hydrochloride enteric-coated tablets in healthy subjects assessing safety for depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ammoxetine Hydrochloride Enteric-coated Tablets (ammoxetine hydrochloride)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Depression | Phase 1 | Status: UNKNOWN